These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8188163)

  • 21. [Short communication: evaluation of the correlation between hepatitis D virus (HDV) RNA positivity and HDV antibodies].
    Ozekinci T; Atmaca S; Akpolat N; Temiz H; Arikan E
    Mikrobiyol Bul; 2005 Jul; 39(3):345-9. PubMed ID: 16358495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
    Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
    Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
    Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
    Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.
    Davis GL; Lau JY; Urdea MS; Neuwald PD; Wilber JC; Lindsay K; Perrillo RP; Albrecht J
    Hepatology; 1994 Jun; 19(6):1337-41. PubMed ID: 8188164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
    Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
    J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Delta hepatitis].
    Matsuda S; Okita K
    Ryoikibetsu Shokogun Shirizu; 1995; (7):127-30. PubMed ID: 8749435
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.
    Farci P; Karayiannis P; Brook MG; Smedile A; Lai ME; Balestrieri A; Saldanha JA; Monjardino J; Gerin J; Thomas HC
    Q J Med; 1989 Nov; 73(271):1045-54. PubMed ID: 2623137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.
    Marzano A; Ottobrelli A; Spezia C; Daziano E; Soranzo ML; Rizzetto M
    Ital J Gastroenterol; 1992; 24(3):119-21. PubMed ID: 1562748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial.
    Gaudin JL; Faure P; Godinot H; Gerard F; Trepo C
    Liver; 1995 Feb; 15(1):45-52. PubMed ID: 7776857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Italian trials of interferon alpha in chronic delta hepatitis.
    Rosina F; Saracco G; Cozzolongo R; Costa C; Bonino F; Verme G; Rizzetto M
    Prog Clin Biol Res; 1993; 382():353-8. PubMed ID: 8502703
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with viremia and elevated transaminase levels in asymptomatic hepatitis D virus-infected risk groups.
    Wu JC; Li CS; Chen CL; Sheng WY; Lee SD; Lo KJ
    J Med Virol; 1994 Jan; 42(1):86-90. PubMed ID: 8308525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
    Farci P; Roskams T; Chessa L; Peddis G; Mazzoleni AP; Scioscia R; Serra G; Lai ME; Loy M; Caruso L; Desmet V; Purcell RH; Balestrieri A
    Gastroenterology; 2004 Jun; 126(7):1740-9. PubMed ID: 15188169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.